| This week's sponsor is CMIC Group. | |  | |
Today's Rundown Featured Story | | | Monday, September 16, 2019 Lundbeck has struck a deal to buy Alder BioPharmaceuticals for almost $2 billion. The takeover centers on a near-approval anti-CGRP antibody that could address Lundbeck’s need for revenue drivers to mitigate the loss of patent protection on Northera. |
|
|---|
|
| This week's sponsor is Millipore Sigma. | |  | |
Top Stories Monday, September 16, 2019 In a landmark vote on Friday, an advisory panel recommended Aimmune’s peanut allergy immunotherapy for FDA approval. The treatment, which desensitizes patients by giving them gradually increasing doses of peanut protein, could be a game-changer. Monday, September 16, 2019 This year marks the 17th time we’ve sought out the best private biotech companies, and as we look forward to officially becoming an adult next year, we thought it high time to see how our alumni are getting on. Monday, September 16, 2019 With more complex molecules in development, changing capacity needs, uncertain forecasts and increased competition, the market demands flexibility and innovative approaches to address these challenges. Monday, September 16, 2019 Amplyx Pharmaceuticals revealed early data for a phase 2 study of its lead program in the fungal infection candidemia and licensed a phase 2-ready program for the treatment of BK virus infection from Novartis. Monday, September 16, 2019 Johnson & Johnson has tasked AlivaMab Discovery Services with finding antibody-drug candidates against multiple targets. The project is built on the AlivaMab Mouse platform that is already used by in-house R&D teams at large biopharma companies. Monday, September 16, 2019 The end goal is to create a “connected device experience” for people managing their diabetes, according to the two companies, through new smart insulin pens, smartphone apps for titration and cloud-based software analytics. Monday, September 16, 2019 Atara Biotherapeutics is developing T cells that target Epstein-Barr virus, which is known to play a role in multiple sclerosis. In a phase 1 trial, all of the patients who received the highest of the two doses showed at least a partial improvement. Monday, September 16, 2019 As the White House continues its push for the benefits of "right to try," the first CRO associated with the law has come onto the stage. | This week's sponsor is LabConnect. | |  |
LabConnect is the preeminent provider of central laboratory support services for logistically and analytically complex studies - customizable to meet the unique needs of your clinical trials. We are your connection to confidence. Contact us today. |
Enrollment Showcase | | | October 23-25, 2019 | Chicago, IL | Presented by Biotech Primer BioImmersion: Biotech for the Non-Scientist is a three-day, in-depth course that delves into the scientific details on a broad number of biotechnology topics. Register today! |
|
|---|
|
Resources Sponsored by: BioAnalytix Download the White Paper and learn how detailed characterization can guide successful development of gene therapy products. Sponsored by: Blue Matter, strategic consultants in the life sciences White paper providing an overview of precision medicine in oncology, as well as a look ahead at future developments and keys to success for pharmaceutical and diagnostics companies. Sponsored by: Patheon, by Thermo Fisher Scientific Avoid potential risks to the patient as well as costly interruptions during development. Sponsored by: Outer Edge Technology Find out how outsourcing your IT requirements enhances the bottom line while creating strategic advantage. Sponsored by: Vineti Developing a cell therapy, gene therapy, or personalized cancer vaccine? Modern data management makes a critical difference in operational and regulatory outcomes. This whitepaper will help your team leverage the latest data strategies for success. Sponsored by: AlphaSense AI-powered research tools are making it easier to source confident healthcare market intelligence with accuracy and efficiency -- download now to learn more about improving your competitive research strategy. Sponsored by: Elemental Machines Your lab is talking to you, are you listening? Sponsored by: Frenova Want to be sure your renal research protocol design is fit for the real world? Sponsored by: Recro Gainesville Vetting CDMOs but unsure what to look for in prospective partners’ multiproduct facilities? Sponsored by: Accenture Clinical trials are one of the pharma industry’s most painful and costly processes. Read how technology could transform the trial process from nine years to a matter of hours. Sponsored by: Baxter BioPharma Solutions Check out Baxter BioPharma Solutions’ whitepaper to learn considerations and options for developing a product in a prefilled syringe. Sponsored by: Alexander Group From sales headcount and budgets to new product launches and saying “yes” to millennials, hear the top 7 topics that are trending in sales compensation. Sponsored by: Kinaxis Download this life sciences industry spotlight to discover how concurrent planning can help you overcome complex supply chain challenges to drive down costs and improve efficiency. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. | 
